Dr. KSS Posts from Biotech Showcase 2018, San Francisco

by DrKSSMDPhD | January 8, 2018 10:44 am

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/2018/01/dr-kss-posts-from-biotech-showcase-2018-san-francisco/


503 responses to “Dr. KSS Posts from Biotech Showcase 2018, San Francisco”

  1. linling88 says:

    $liquidBiopsy $BIOC
    $AI $MachineLearning $NVDA

    “CancerSEEK: Blood Test That Detects Eight Common Cancers”

    Alexander M. Castellino, PhD
    January 18, 2018
    A new blood test, dubbed CancerSEEK, can identify eight common cancers ― ovary, liver, esophagus, pancreas, stomach, colorectal, lung, and breast cancer ― say researchers from the Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland.
    The new test measures circulating tumor DNA (ctDNA) from 16 genes as well as eight protein biomarkers, and then uses machine-based learning to analyze the data.

    The use of a combination of selected biomarkers for early detection has the potential to change the way we screen for cancer, and it is based on the same rationale for using combinations of drugs to treat cancers,” said Nickolas Papadopoulos, PhD, senior author and professor of oncology and pathology, in a statement.

    In the future, the blood test could be used to detect cancers “early enough that they could be cured by surgery alone, but even cancers that are not curable by surgery alone will respond better to systemic therapies when there is less advanced disease,” said one of the corresponding authors, Anne Marie Lennon, MD, PhD, professor of medicine, surgery, and radiology and clinical director of gastroenterology. “Earlier detection provides many ways to improve outcomes for patients,” she added.
    The new test is described in a report published online January 18 in Science.[…]

    https://www.medscape.com/viewarticle/891491